◀ Back to VIP
NPS — VIP
Pathways - manually collected, often from reviews:
Text-mined interactions from Literome
Anand et al., Br J Dermatol 1991
(Dermatitis, Atopic...) :
Neuropeptides in skin disease :
increased VIP in eczema and psoriasis but not axillary hyperhidrosis
Camilleri et al., Gastroenterology 2010
(Gastrointestinal Diseases...) :
NPS-NPSR1 signaling
induced increased expression of cholecystokinin,
vasoactive intestinal peptide , peptide YY, and somatostatin
Edvinsson et al., Cephalalgia 1995
(Cluster Headache...) :
These
neuropeptides mediate contraction ( NPY ) and dilation (
VIP , SP, CGRP )
Cai et al., Endocrinology 1997
:
Regulation of Interleukin-6 (IL-6) production in bone marrow ( BM ) -derived stromal cells by
neuropeptides , pituitary adenylate cyclase activating polypeptide ( PACAP ) and
vasoactive intestinal peptide (VIP) , was examined